Trials / Conditions / Adjuvant Immunotherapy
Adjuvant Immunotherapy
3 registered clinical trials studyying Adjuvant Immunotherapy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698 | Guangdong Association of Clinical Trials | Phase 2 |
| Not Yet Recruiting | A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based NCT06977828 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Completed | Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelli NCT06298123 | Chen Xiaoping | — |